A community study using specified and unspecified scenarios to investigate men's views about PSA screening

被引:7
作者
Gattellari, M [1 ]
Ward, JE [1 ]
机构
[1] S Western Sydney Area Hlth Serv, Div Populat Hlth, Liverpool, NSW, Australia
关键词
community survey; decision-making; intention to screen; prostate-specific antigen screening;
D O I
10.1111/j.1369-7625.2004.00285.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective We explored the influence of different but factual scenarios about prostate-specific antigen (PSA) screening on men's interest in having PSA screening to detect early prostate cancer. Design Cross-sectional, representative community survey. Setting and participants A total of 514 men (89% response fraction) aged 50-70 years randomly selected from a telephone directory database in Sydney., Australia. Main variables studied Demographic, health and psychological variables. Main outcome variables Interest in undergoing screening in response to five unspecified scenarios and, elsewhere in our interview, a specified scenario in which PSA screening was mentioned explicitly. Results When presented with a scenario describing a lack of evidence underpinning the efficacy of screening for an unspecified cancer, 61.2% of men reported that they 'probably' or 'definitely' wanted to undergo screening for an unspecified cancer. Similar proportions reported that they 'probably' or 'definitely' wanted to undergo screening even at the risk of unmasking indolent cancer (60.9%) or without expert consensus about the value of screening (62.8%). Greatest interest in screening was elicited in that scenario describing life-time risk of dying from prostate cancer (72.6%) (P < 0.001). Significantly fewer indicated they would 'probably' or 'definitely' want to undergo screening for a cancer for which there was uncertainty about treatment efficacy and known side-effects (46.1%) (P < 0.001). Increasing age was a consistent predictor of positive interest in screening. When asked later in our survey specifically about PSA screening, 68.1% 'probably' or definitely' wanted PSA screening. Conclusion Public health policy makers need to ensure that men are provided with the scope of medical evidence germane to prostate cancer screening and treatment. thereby potentially improving prostate cancer screening decisions.
引用
收藏
页码:274 / 289
页数:16
相关论文
共 34 条
[1]  
*ABS, 1997, AUSTR STAND CLASS OC
[2]  
Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473
[3]   Gaining informed consent for screening [J].
Austoker, J .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7212) :722-723
[4]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[5]  
*CAN CANC SOC, CAN CANC SOC PERSP E
[6]  
*CANC COUNC AUSTR, 2001, NAT CANC PREV POL 20
[7]  
Catalona WJ, 2003, UROLOGY, V61, P17, DOI 10.1016/S0090-4295(02)02007-1
[8]  
COATES M, 2000, CANC NEW S WALES INC
[9]  
Davey Heather M, 2002, Health Expect, V5, P330, DOI 10.1046/j.1369-6513.2002.00194.x
[10]   Prostate cancer mortality reduction by screening:: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial [J].
de Koning, HJ ;
Liem, MK ;
Baan, CA ;
Boer, R ;
Schröder, FH ;
Alexander, FE .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :268-273